We have examined the effects of the protein kinase C (PKC)-activator phorbol 12-myristate 13-acetate (PMA) on gene expression in two breast cancer cell (BCC) lines exhibiting highly different phenotypes. These are the estrogen receptor · (ER·)-positive, weakly invasive, luminal epithelial-like MCF-7 and the ER·-negative, highly invasive, fibroblast-like MDA-MB-231. They express constitutively low and high PKC activities, respectively. After a 24-h exposition to 100 nM PMA, the number of genes showing an altered expression at the 2-fold change level was much higher in MCF-7 (n=435) than in MDA-MB-231 (n=18) BCC. Four of these genes, namely CDC2, CENPA, NR4A1 and MMP10, were altered in the same way in both cell lines. Two genes were regulated in an opposite way: ID1 and EVA1. Many of the genes down-regulated in MCF-7 BCC appeared to be preferentially expressed in the G 1 , S, and/or G 2 phases of the cell cycle. The ER· gene, ESR1, and other genes associated to the ER·-positive, luminal epithelial-like BCC phenotype were down-regulated, while a series of genes related to a more aggressive, fibroblast-like BCC phenotype were up-regulated. Other altered genes were notably linked to cell architecture, supporting profound effects of PMA on cell morphology and motility, as well as on the interactions between BCC and their neighboring proteins. Of note, all the modulated genes involved in proteolysis and its control were up-regulated. In summary, PMA effects suggest that PKC activation may induce, to some extent, a more fibroblast-like phenotype in the ER·-positive, luminal epithelial-like MCF-7 BCC, and significantly modulate the interactions of these cells with their environment.
Introduction
Based on the initial observation that it was able to promote skin tumor formation, phorbol 12-myristate 13-acetate (PMA) has been widely used in experimental oncology. PMA is an activator of various isoforms of protein kinase C (PKC). Total PKC activity is elevated in breast cancer tissues, suggesting an association with tumorigenicity (1) . In breast cancer cell (BCC) lines, a relation has been found between a high PKC activity and the absence of estrogen receptor · (ER·), and PKC activity is generally higher in aggressive and invasive BCC lines (2) . Treatment with PMA has been shown to drastically increase the invasiveness of low-PKC-expressing, ER·-positive MCF-7 BCC. A PKC inhibitor (H7) reversed the PMA effects on these cells. Similar effects of PMA were observed for cell chemo-taxis (3) . A prolonged (hours) exposure of MCF-7 to PMA led to a significant growth reduction, an effect seen to a much lesser extent in MDA-MB-231 cells (4) . In MCF-7 BCC stably transfected with the PMA-responsive protein kinase C · isoform, various changes were observed: enhanced proliferation rate, anchorageindependent growth, dramatic morphologic alterations including loss of an 'epithelioid' appearance, significant increase in the level of the mesenchymal/fibroblastic marker vimentin, increased tumorigenicity in nude mice, a significant reduction in ER· expression, and a decrease in estrogendependent gene expression (5) . These observations suggest that PKC activation by PMA may produce considerable changes in gene expression, at least in MCF-7 BCC.
The introduction of DNA micro-array use in oncology may notably allow dissecting the gene response associated to the activation of specific signaling pathways. Here, we have applied this technology to examine the gene expression patterns in MCF-7 and MDA-MB-231 cells exposed to PMA.
Materials and methods
Cell culture. MCF-7 and MDA-MB-231 cells were obtained from ATCC (Rockville, MD, USA). These BCC lines express very different phenotypes. MCF-7 cells are ER·-positive, weakly invasive in vitro, and exhibit a series of markers characteristic of the luminal cells of the breast epithelium. Table I . The 50 genes most up-or down-regulated by PMA in MCF-7 BCC. 
MDA-MB-231 BCC are ER·-negative, highly invasive in vitro, and share a series of markers with mesenchymal cells such as fibroblasts. However, their epithelial nature is notably supported by the fact that they express, although to a low extent, the cytokeratins 8, 18, and 19 (6) (for an extensive review on BCC lines, including MCF-7 and MDA-MB-231, see ref. 7) . Both cell lines were routinely cultured in MEM medium added with 5% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (Life Technologies). PMA was from Sigma.
RNA extraction and probe preparation. Isolation of RNA was performed using TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The quality of the RNA was assessed based on the RNA profile generated by the bioanalyzer (Agilent Inc.). Total RNA was linearly amplified using a modification of the Eberwine method (8) . Briefly, total RNA was reverse-transcribed by using a 63 nucleotide synthetic primer containing the T7 RNA polymerase binding site (5'-GGCCAGTGAATTGTAATACGACTCACTATA GGGAGGCGG(T) 24 -3'. Second strand cDNA synthesis (producing double-stranded cDNA) was performed with RNase H, E. coli DNA polymerase I, and E. coli DNA ligase (Invitrogen, Carlsbad, CA). After cDNA was blunt-ended with T4 DNA polymerase (Invitrogen), it was purified by phenol-chloroform-isoamyl alcohol extraction and ammonium acetate-ethanol precipitation. The double-stranded cDNA was then transcribed using T7 polymerase (T7 Megascript Kit, Ambion, Austin, TX), yielding amplified anti-sense RNA which was purified using RNeasy mini-columns (Qiagen, Valencia, CA). Total RNA from the Universal Human Reference (UHR) (Stratagene) was amplified and used as reference for cDNA micro-array analysis. The cDNA microarray chips consisted of 10,369 total features, and were manufactured at the Jules Bordet Institute micro-array facility.
Amplified RNA (3 µg) was reverse-transcribed and directly labeled using cyanine 5-conjugated dUTP (tumor RNA) or cyanine 3-conjugated dUTP (UHR). Hybridization was performed in the presence of 5X SSC and 25% formamide for 14-16 h at 42˚C. Slides were washed, dried, and scanned using an Axon 4000a laser scanner. A detailed protocol for RNA amplification as well as cDNA probe labeling and hybridization is available on the web at http://nciarray.nci. nih.gov/reference/index.shtml. To exclude labeling biases, amplified RNA from each cell line and condition were labeled with the reciprocal fluorochrome in a duplicate experiment.
Scanning and data processing. Following hybridization, microarrays were scanned using a 10 µm resolution GenePix 4000 scanner (Axon Instruments, Inc., Foster City, CA) at variable PMT (photo-multiplier tube) voltage to obtain maximal signal intensity with <1% probe saturation. Resulting TIFF images for each fluorescent were analyzed with GenePix software version 3.0 (Axon Instruments, Inc., Foster City, CA). The data files generated by GenePix v3.0 were entered into a web-based database maintained by the Microarray Unit, Jules Bordet Institute.
Data analysis. Expression profiles were analyzed using BRB Array tools, version 3.0 (Molecular Statistics and Bioinformatics Section, National Cancer Institute, Bethesda, USA). For each fluorescent channel, the log-ratios were normalized by subtracting the median log-ratio from each experiment. Spots of any experiment, which had red and/ or green intensity <250 units after subtraction to the background, a spot size <25 pixels or flagged for any experimental reason were filtered out. Differentially expressed genes were designated significant if they were reproducibly induced by >2-fold in the two reciprocal experiments for each cell line and condition.
A Java-based program called Onto-Express (9) was used to determine whether clusters of genes with similar expression profiles were enriched in specific GO functional categories. Based on the genes present on the chip, OntoExpress calculated the expected number of occurrences of each functional category in each cluster. For the current experiments, a binomial model was selected to calculate the probability that each functional category was overrepresented in a cluster and the p-values were corrected for the multiplicity using the false discovery rate method (10).
Results and Discussion
Differential gene regulation by PMA in MCF-7 and MDA-MB-231 BCC. Upon a 24-h exposure to 100 nM PMA, the expression of 197 genes was increased and that of 238 genes was decreased >2-fold in MCF-7 BCC. The 25 most up-or down-regulated genes in MCF-7 are listed in Table I . In MDA-MB-231 cells, only 18 genes were modulated (9 downand 9 up-regulated, as shown in Table II ). This considerable difference is in line with previous data indicating that the growth-arrest effect of PMA was much higher in MCF-7 than in MDA-MB-231 cells. This has been attributed to the presence of higher levels of the ‰ isoform of PKC (PKC‰) in MCF-7 (11) . Whether the PKC‰ level may also explain the differential modulation of gene expression by PMA in the two cell lines is, however, presently unknown.
We found that PMA notably decreased the PKC‰ gene (PRKCD) expression level in MCF-7 cells (Table I) . Previous observations have related decreased PKC‰ amount to the acquisition of a more aggressive neoplastic phenotype in MCF-7 cells stably transfected with the alpha isoform of PKC (PKC·) (5). However, the growth-arrest response of BCC to PMA has been linked to their PKC‰ level. We suggest that a PKC·-mediated reduction of PKC‰ activity in MCF-7 cells could partly desensitize them to the growth-inhibiting effects of the phorbol ester.
In contrast to PKC‰, constitutive PKC· and total PKC activities are much lower in MCF-7 than in MDA-MB-231 BCC (2, 3) . PMA treatment may enhance these PKC activities to a much higher extent in the former than in the latter cells, which we expected to result in a more extensive modulation of gene expression in MCF-7 cells. This was effectively observed here. On the other hand, a number of genes that were up-or down-regulated by PMA in MCF-7 are known to be constitutively expressed at a high or low-level, respectively, in MDA-MB-231 cells. This is notably the case for genes associated to the fibroblast-like and luminal epithelial-like phenotypes (see below). We suggest that the amount of expression of these genes could not be further altered by PMA in MDA-MB-231 BCC. ONCOLOGY REPORTS 12: 701-707, 2004 Genes modulated by PMA in MCF-7. By using the Gene Ontology software, genes having an expression level altered by PMA in MCF-7 BCC were classified according to three criteria, based on their protein product. These criteria were: a) the molecular function of the protein (Fig. 1A) ; b) the biological process in which it is involved (Fig. 1B) ; c) the cellular component where it is localized (Fig. 1C) . Regarding function, a significantly high number of genes were associated to ATP binding, DNA binding, hydrolase activity, receptor activity, and protein serine/threonine kinase activity. This is consistent with energy-driven changes in signalling and DNA-associated events. Gene classification according to biological processes supported an important role for PMA in DNA metabolism and regulation of cell cycle/apoptosis. Finally, the cellular component analysis confirmed the extent of nuclear events in PMA action (Fig. 1) .
A literature-based analysis of the modulated genes was also conducted. We found that about 22% of the genes regulated by PMA in MCF-7 cells were known to be expressed at a higher level in late G 1 , S, and/or G 2 phases of the cell cycle (see notably ref. 12). The great majority of these genes were down-regulated, in agreement with the well-known growtharrest effect of PMA (4, 11) .
The expression of a series of genes associated to the ER·-positive, luminal epithelial-like phenotype of BCC was also decreased. These genes included the ER· gene (ESR1) itself, estrogen-induced genes such as BCL2 (B-cell CLL/ lymphoma 2), LIV-1 [now SLC39A12 -solute carrier family 39 (zinc transporter), member 12], PGR (progesterone receptor), RERG (RAS-like, estrogen-regulated, growth-inhibitor), TFF3 (trefoil factor 3) and other genes known to be co-expressed with the ER in BCC lines, such as GPR30 (G protein-coupled receptor 30), IGFBP5 (insulin-like growth factor binding protein 5), MYB (v-myb avian myeloblastosis viral oncogene homolog), NAT1 (N-acetyltransferase 1), SELENBP1 (selenium-binding protein 1), SYK (spleen tyrosine kinase), VAV3 (vav 3 oncogene) (reviewed in ref. 7) . Another downregulated gene, AIBZIP (now CREB3L4 -cAMP responsive element binding protein 3-like 4), was previously shown to be androgen-inducible and expressed in androgen-dependent but not -independent prostate cell lines (13) . Our data suggest that it could be similarly related to the estrogen-responsive status of BCC lines.
In contrast, a series of genes associated to the fibroblastlike and/or ER·-negative phenotype of BCC were up-regulated. Expression of most of these genes has been previously reported to be lower in MCF-7 than in MDA-MB-231 cells. 
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The data indicating that PMA may induce, to some extent, a phenotype change in MCF-7 cells are in agreement with previous reports. It was notably shown that the stable transfection of PKC· in these cells produced dramatic morphologic alterations including loss of an epithelioid appearance, a significant reduction in ER· expression, and a decrease in estrogen-dependent gene expression. A significant increase in the level of the fibroblastic/mesenchymal marker vimentin was also observed (5). Many genes regulated by PMA were associated to specific cell properties or features. Only a few examples will be given here.
A series of genes were related to cell adhesion and cell architecture. Most were up-regulated by PMA, and their identity supports a profound effect of PKC activation on actin fiber dynamics, cell spreading and motility, and signaling from the extra-cellular matrix.
Thus, several genes coding for extra-cellular matrix components were increased: FN1, LAMB3, MFGE8 (milk fat globule-EGF factor 8 protein), MGP (matrix Gla protein). While some genes coding for cell adhesion molecules, notably integrins components, were increased (ICAM1, ITGA3, ITGA5 ), other were decreased (DSCAM, down syndrome cell adhesion molecule; ITGAE, integrin · E). The actin Á1 gene (ACTG1), was up-regulated, while genes encoding actin fiber-organizing proteins were either increased (ACTN1, actinin · 1; VIL2, villin 2) or decreased (EPLIN, epithelial protein lost in neoplasm ß). KRT1 (keratin 1), a component of intermediate filaments, was increased. Focal adhesion plaques are structures that form at the ends of actin fibers and serve as sites of force transmission. The integrins are present at these plaques and connect extra-cellular matrix components to actin filaments, through the action of many actin-attachment proteins and other cytoplasmic adhesion proteins. Two components of focal adhesion plaques, SDC4 (syndecan 4) and ZYX (zyxin) were up-regulated, as was CAPN2 (calpain-2), which modulates zyxin-actinin relations.
One interesting feature was that all the modulated genes identified as participating in proteolysis and proteolysis inhibition were up-regulated by PMA. These included CSTB Genes modulated by PMA in both MCF-7 and MDA-MB-231 cells. Six genes were modulated by PMA in both MCF-7 and MDA-MB-231 cells. They are listed in Table III . CDC2 (cell division cycle 2) and CENPA (centromere protein A) are know to be cell cycle-associated, culminating in G 2 /M phase. Their observed down-regulation in both cell lines is in agreement with the previously described growth-arrest effects of PMA (see e.g. ref. 11). NR4A1 (nuclear receptor subfamily 4, group A, member 1) was up-regulated in both cell lines. Its protein product is also known as Nur-77 or NGFI-B (nerve growth factor-induced clone B). NR4A1 is an immediate early response gene for a number of growth factors signaling pathways and has been implicated in cell proliferation, differentiation, and apoptosis. Its induction by PMA has been previously described in MCF-7 (14), but not in MDA-MB-231 cells. In gastric cancer cells, PMA has been shown not only to up-regulate the NR4A1 mRNA level, but also to lead to translocation of NR4A1 protein from the nucleus to the mitochondria, which causes the release of cytochrome c and the triggering of apoptosis (15) . Whether this may occur in PMAtreated BCC remains to be established. MMP10 encodes a member of the stromelysin family of matrix metalloproteinases, which have a broad substrate specificity and may notably degrade several extra-cellular matrix (ECM) components (laminin, fibronectin, non-fibrillar collagens) (16) . MMP10 is specifically expressed in epithelial cells and has previously been detected in MCF-7 and MDA-MB-231 BCC (17, 18) . Strong MMP10 expression has been observed in breast carcinomas, especially in the ECM adjacent to blood vessels (19) . As two PMA-responsive, AP-1 transcription factorbinding sites are present in the MMP10 promoter (20) , they could mediate the induction of this gene by the phorbol ester in both MCF-7 and MDA-MB-231. This induction is expected to give to the BCC a higher ability to degrade ECM.
Three genes were regulated in an opposite way in MCF-7 and MDA-MB-231 BCC: ID1 and EVA1. ID1 was up-regulated by PMA in MCF-7, while it was and down-regulated in MDA-MB-231 cells. Basic loop-helix-loop (bHLH) transcription factors regulate the differentiation programs in various cells. The Id family of proteins (comprised of four members designated Id1-Id4) does not possess a basic DNA binding domain and function as dominant-negative regulator of bHLH proteins by hetero-dimerizing with the latter. In BCC, Id1 has been associated with proliferation, apoptosis, and pheno-type definition (21) . It has been shown that ID1 is constitutively expressed at a high level in ER·-negative, fibroblast-like MDA-MB-231 and MDA-MB-435 BCC, but not in ER·-positive, luminal epithelial-like MCF-7 and T-47D cells and, in general, in normal luminal epithelial cells of mammary glands (22) . In T-47D cells, it is, however, induced by serum and estrogens, but repressed by progesterone (23) . An ID1 cDNA, constitutively expressed in the non-aggressive T-47D cells, conferred to these cells a more aggressive phenotype, as measured by growth and invasiveness (23) . Our data suggest that Id1 could play a role in the PMA-mediated induction of a more fibroblast-like or 'dedifferentiated' phenotype in the luminal epithelial-like MCF-7, while its down-regulation could attenuate, to some extent, the expression of this fibroblastlike phenotype in MDA-MB-231 cells. This latter effect, however, is unlikely to be extensive, considering that only a few genes appeared to be modulated by PMA in these cells. EVA1 encodes a transmembrane glycoprotein, (epithelial Vlike antigen) expressed in various epithelia and first identified as homotypic adhesion molecule involved in thymus histogenesis (24) . To our knowledge, its role in breast cancer has not been extensively studied. Its modulation could alter the cell-cell and cell-environment interactions in breast tumors.
In conclusion, our micro-array-based study supports previous observations indicating that the BCC response to the PKC-activator PMA is variable. The ER·-positive, luminal epithelial-like, weakly invasive MCF-7 appeared much more responsive to the phorbol ester than the ER·-negative, fibroblast-like, highly aggressive MDA-MB-231 cells. Our study revealed genetic changes consistent with profound effects of PMA on MCF-7 cell growth, architecture, and interactions with their environment. Table III . Genes regulated by PMA in both MCF-7 and MDA-MB-231 BCC.
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